rs28730711

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001232.4(CASQ2):​c.1194T>C​(p.Asp398Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0561 in 1,612,070 control chromosomes in the GnomAD database, including 2,957 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.048 ( 272 hom., cov: 32)
Exomes 𝑓: 0.057 ( 2685 hom. )

Consequence

CASQ2
NM_001232.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.757

Publications

6 publications found
Variant links:
Genes affected
CASQ2 (HGNC:1513): (calsequestrin 2) The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008]
CASQ2 Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 1-115701247-A-G is Benign according to our data. Variant chr1-115701247-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 44159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.757 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0917 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASQ2NM_001232.4 linkc.1194T>C p.Asp398Asp synonymous_variant Exon 11 of 11 ENST00000261448.6 NP_001223.2 O14958-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASQ2ENST00000261448.6 linkc.1194T>C p.Asp398Asp synonymous_variant Exon 11 of 11 1 NM_001232.4 ENSP00000261448.5 O14958-1

Frequencies

GnomAD3 genomes
AF:
0.0484
AC:
7367
AN:
152080
Hom.:
272
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0113
Gnomad AMI
AF:
0.131
Gnomad AMR
AF:
0.0960
Gnomad ASJ
AF:
0.0620
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0386
Gnomad FIN
AF:
0.0435
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0633
Gnomad OTH
AF:
0.0603
GnomAD2 exomes
AF:
0.0566
AC:
14218
AN:
251300
AF XY:
0.0563
show subpopulations
Gnomad AFR exome
AF:
0.00966
Gnomad AMR exome
AF:
0.104
Gnomad ASJ exome
AF:
0.0604
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0464
Gnomad NFE exome
AF:
0.0630
Gnomad OTH exome
AF:
0.0541
GnomAD4 exome
AF:
0.0569
AC:
83038
AN:
1459872
Hom.:
2685
Cov.:
30
AF XY:
0.0570
AC XY:
41397
AN XY:
726418
show subpopulations
African (AFR)
AF:
0.00922
AC:
308
AN:
33416
American (AMR)
AF:
0.101
AC:
4497
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0636
AC:
1661
AN:
26132
East Asian (EAS)
AF:
0.000302
AC:
12
AN:
39698
South Asian (SAS)
AF:
0.0466
AC:
4014
AN:
86190
European-Finnish (FIN)
AF:
0.0484
AC:
2584
AN:
53404
Middle Eastern (MID)
AF:
0.0474
AC:
272
AN:
5744
European-Non Finnish (NFE)
AF:
0.0599
AC:
66520
AN:
1110268
Other (OTH)
AF:
0.0526
AC:
3170
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
4241
8483
12724
16966
21207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2384
4768
7152
9536
11920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0484
AC:
7369
AN:
152198
Hom.:
272
Cov.:
32
AF XY:
0.0489
AC XY:
3636
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.0113
AC:
471
AN:
41534
American (AMR)
AF:
0.0958
AC:
1466
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0620
AC:
215
AN:
3468
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5184
South Asian (SAS)
AF:
0.0389
AC:
187
AN:
4812
European-Finnish (FIN)
AF:
0.0435
AC:
461
AN:
10590
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0633
AC:
4307
AN:
67994
Other (OTH)
AF:
0.0597
AC:
126
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
355
710
1066
1421
1776
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0516
Hom.:
175
Bravo
AF:
0.0492
Asia WGS
AF:
0.0190
AC:
65
AN:
3478
EpiCase
AF:
0.0661
EpiControl
AF:
0.0625

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Catecholaminergic polymorphic ventricular tachycardia 2 Benign:4
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 17, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Sep 16, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Caudal regression sequence Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neural tube defect Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 23, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.50
DANN
Benign
0.71
PhyloP100
-0.76
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28730711; hg19: chr1-116243868; COSMIC: COSV54768379; COSMIC: COSV54768379; API